Literature DB >> 21264678

Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit.

F Gona1, M L Mezzatesta, D Corona, D Zerbo, V Scriffignano, S Stefani, P Veroux, M Veroux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21264678     DOI： 10.1007/s15010-011-0081-0

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  20 in total

1.  Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors:  Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Addressing the challenge of extended-spectrum beta-lactamases.

Authors:  Jean-Ralph Zahar; Olivier Lortholary; Claude Martin; Gilles Potel; Patrick Plesiat; Patrice Nordmann
Journal:  Curr Opin Investig Drugs       Date:  2009-02

3.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey.

Authors:  Francesco Luzzaro; Marilina Mezzatesta; Claudia Mugnaioli; Mariagrazia Perilli; Stefania Stefani; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Toniolo
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Epidemiology of urinary infections in renal transplant recipients.

Authors:  B Valera; M A Gentil; V Cabello; J Fijo; E Cordero; J M Cisneros
Journal:  Transplant Proc       Date:  2006-10       Impact factor: 1.066

8.  Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

Authors:  M Quinteros; M Radice; N Gardella; M M Rodriguez; N Costa; D Korbenfeld; E Couto; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

10.  Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.

Authors:  S P Kuster; B Hasse; V Huebner; V Bansal; R Zbinden; C Ruef; B Ledergerber; R Weber
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553
View more
  3 in total

1.  Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.

Authors:  S Shilo; M V Assous; T Lachish; P Kopuit; T Bdolah-Abram; A M Yinnon; Y Wiener-Well
Journal:  Infection       Date:  2012-12-28       Impact factor: 3.553

2.  The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria.

Authors:  F G De Rosa; N Pagani; L Fossati; S Raviolo; C Cometto; P Cavallerio; C Parlato; E Guglielmi; R Serra; G Di Perri
Journal:  Infection       Date:  2011-11-03       Impact factor: 3.553

Review 3.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.